TVM Capital Healthcare Invests $17 Million in Neurocare
This marks the ninth investment by TVM Capital Healthcare aimed at enhancing healthcare accessibility and quality across the MENA region.
TVM Capital Healthcare, a private equity firm focusing on healthcare with headquarters in Dubai and Singapore, has invested $17 million in Munich-headquartered healthtech Neurocare Group AG. Thomas Mechtersheimer founded Neurocare in 2015 as a provider of individualized mental health care. [1]
The infusion of funds will fortify neurocare's international growth endeavors, particularly in the US and Saudi Arabian markets, as well as support the development of new hardware and software innovations.
This marks the ninth investment by TVM Capital Healthcare aimed at enhancing healthcare accessibility and quality across the MENA region.
Neurocare's digital therapy platform (DTP) offers treatment options for an array of psychological and neurological conditions, such as sleep assessment, therapeutics, psychotherapy, transcranial magnetic stimulation (TMS), and neurofeedback.
